FDA approves first Alzheimer’s therapy shown to… The first Alzheimer’s drug proven to moderately slow the course of the disease gained full approval from the…
Alzheimer’s drug approval unlikely to ease… An ongoing fight among Medicare officials, Alzheimer’s patient groups and lawmakers over coverage of a new…
FDA advisers endorse Alzheimer’s drug for full… Outside advisers to the Food and Drug Administration (FDA) on Friday unanimously recommended the agency grant…
Medicare won’t change coverage policy for pricey… Medicare will continue to restrict coverage of a new class of Alzheimer’s drugs, even when they have been fully…
Medicare, FDA urged to press ahead with new… Patients, lawmakers and Alzheimer’s advocates are pushing for Medicare to fully cover a new drug for treating…